John Maddalena, Ph.D.

Vice President, Scientific Strategy

The continuous growth of our analytical CMC and bioanalytical services reflects our commitment to delivering the science our customers need.

John Maddalena, Ph.D., joined Haematologic Technologies in 1992. He was responsible for the development and implementation of a quality management system (QMS) and subsequent ISO 9001 registration to support Prolytix’s manufacturing activities. More recently, John assumed oversight responsibilities for Prolytix’s GMP operations which focuses on providing GMP analytical testing services to support the development and release of protein therapeutics. He specializes in the development and validation of analytical test methods.

John received his B.S. in microbiology from the University of Notre Dame and his Ph.D. in cellular and molecular biology from the University of Vermont. John also holds an M.Ed. from the University of Massachusetts.